Breaking News

Arranta Bio Invests in New Manufacturing Facility

Addition of 130,000 sq. ft. Boxborough, MA, manufacturing facility to supply clinical and commercial microbiome products.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Arranta Bio, a microbiome contract development and manufacturing organization (CDMO), has added a 130,000 square foot facility in Boxborough, MA, to complement its existing facilities in Watertown, MA and Gainesville, FL, bringing the total manufacturing capacity at Arranta to over 230,000 square feet. Arranta closed an oversubscribed Series B equity financing from its current investors to fund the expansion.   The Boxborough site will be developed in phases, and work on the first two phases has...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters